The Latest Breaking News from FDA

India Globalization Capital, Inc. (AMEX:IGC) announced that the United States Patent and Trademark Office issued a second patent (#11,446,276) for the treatment of Alzheimer’s disease entitled “Extreme low dose THC as a therapeutic and prophylactic agent for Alzheimer’s disease.”

As the administration prepares for its Sept. 28 hunger conference, the food industry is wary of new labeling mandates.

In March, experts who advise the FDA questioned the efficacy of an experimental new drug for ALS. In September, they voted to approve it anyway.

TikTok users are apparently bringing to cold and flu medicine into the kitchen, with potentially poisonous results

“These video challenges, which often target youths, can harm people — and even cause death,” the agency said.

U.S. health regulators say their response to the ongoing infant formula shortage was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory

As several major food makers are champing at the bit to cash in on the CBD food and drinks craze, it seems the FDA is still not down with the program.

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK),…

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping 400 points on Tuesday.

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 50 points on Tuesday.

Family Dollar says it is not aware of any complaints from customers nor any reports of illnesses related to the recall.